BioCryst Pharmaceuticals | BCRX - Marktkapitalisierung

Aktienkurs
9.56
Täglich Wechseln
-0.33 -3.34%
Monatlich
12.60%
Jährlich
40.18%
Q2 Prognose
9.30




Marktkapitalisierung Veränderung Datum
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
Chugai Pharma JPY 13.84T 3.01T 2025-12
Daiichi Sankyo JPY 6.34T 62.51B 2025-12
DBV Technologies USD 274M 17M 2025-09
Enanta Pharmaceuticals USD 122M 98M 2024-12
Gilead Sciences USD 152.28B 14.55B 2025-12
GlaxoSmithKline GBP 74.36B 10.31B 2025-12
Glaxosmithkline GBP 99.93B 13.05B 2025-12
Incyte USD 19.39B 2.83B 2025-12
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
Karyopharm Therapeutics USD 652M 517M 2026-04
Neurocrine Biosciences USD 14.14B 218M 2025-12
Novavax USD 1.09B 316M 2025-12
PTC Therapeutics USD 6.1B 1.22B 2025-12
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12